recentlymegaslotsHims & Hers Health, a U.S. affordable health care company, announced that it will launch the first compound GLP-1 weight-loss injection, Compounded Semaglutide. Unlike Novo Nordisk and Lilly's expensive weight-loss drugs, which cost up to $1350 a month for injections, this generic weight-loss drug costs only $199 a month, which is 85% cheaper than Novo Nordisk's Wegovy and Lilly's Zepbound.
According to reports, customers who currently hold prescriptions can obtain compound GLP-1 drugs through the Hims & Hers platform. Hims & Hers said it plans to provide GLP-1 branded drugs to customers once supplies stabilize.
Although drugmakers such as Novo Nordisk are making every effort to increase the supply of weight-loss drugs, these drugs have faced intermittent shortages over the past year. And Hims & Hers and other telemedicine companies have found a workaroundmegaslots: Due to supply shortages, the FDA allows these companies to produce composite versions of GLP-1 drugs if safety and effectiveness are guaranteed.
